• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状 RNA circ-MYBL2 是多发性骨髓瘤中一种新型的肿瘤抑制因子和潜在的生物标志物。

circRNA circ-MYBL2 is a novel tumor suppressor and potential biomarker in multiple myeloma.

机构信息

Department of Hematology, The First Affiliated Hospital of Jinzhou Medical University, No.2, Section 5, Renmin Street, Guta District, Jinzhou, 121000, Liaoning, China.

出版信息

Hum Cell. 2021 Jan;34(1):219-228. doi: 10.1007/s13577-020-00441-8. Epub 2020 Oct 15.

DOI:10.1007/s13577-020-00441-8
PMID:33058028
Abstract

Currently, multiple myeloma (MM) is still an incurable disease. Deciphering its pathogenesis will bring new targets for clinical diagnosis and treatment. In the present study, we identified a MM-associated circular RNA (circRNA), circ-MYBL2, which was dramatically decreased in MM tissue and serum samples in comparison to normal samples. Low circ-MYBL2 level was closely correlated with high clinical stage and unfavorable outcome, and serum circ-MYBL2 had excellent accuracy in diagnosing MM. Exogenous circ-MYBL2 expression notably repressed MM cell viability, DNA synthesis and cell cycle progression. Further exploration revealed that circ-MYBL2 exerted the tumor-inhibiting effect by affecting the phosphorylation level of its linear isoform, in which circ-MYBL2 facilitated the binding of Cyclin F to MYBL2, dampening MYBL2 phosphorylation and activation, thereby inhibiting the transcription of a number of well-known proliferation-related oncogenes. Importantly, overexpression of circ-MYBL2 significantly reduced the tumor size of subcutaneous xenografts in nude mice. Taken together, our data unveil a regulatory mechanism linking circ-MYBL2 and its host gene mediated by Cyclin F, providing a potential diagnostic, prognostic and therapeutic target for MM patients.

摘要

目前,多发性骨髓瘤(MM)仍然是一种不可治愈的疾病。解析其发病机制将为临床诊断和治疗带来新的靶点。在本研究中,我们鉴定出一种与 MM 相关的环状 RNA(circRNA),circ-MYBL2,其在 MM 组织和血清样本中的表达明显低于正常样本。低水平的 circ-MYBL2 与高临床分期和不良预后密切相关,血清 circ-MYBL2 对 MM 的诊断具有很高的准确性。外源性 circ-MYBL2 表达显著抑制 MM 细胞的活力、DNA 合成和细胞周期进程。进一步的探索表明,circ-MYBL2 通过影响其线性异构体的磷酸化水平发挥抑瘤作用,其中 circ-MYBL2 促进 Cyclin F 与 MYBL2 的结合,抑制 MYBL2 的磷酸化和激活,从而抑制许多已知的与增殖相关的癌基因的转录。重要的是,circ-MYBL2 的过表达显著减少了裸鼠皮下异种移植瘤的大小。总之,我们的数据揭示了一种由 Cyclin F 介导的 circ-MYBL2 与其宿主基因之间的调控机制,为 MM 患者提供了一个有潜在诊断、预后和治疗价值的靶点。

相似文献

1
circRNA circ-MYBL2 is a novel tumor suppressor and potential biomarker in multiple myeloma.环状 RNA circ-MYBL2 是多发性骨髓瘤中一种新型的肿瘤抑制因子和潜在的生物标志物。
Hum Cell. 2021 Jan;34(1):219-228. doi: 10.1007/s13577-020-00441-8. Epub 2020 Oct 15.
2
Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143.Circ_0006332通过miR-143调节MYBL2表达促进膀胱癌的生长和进展。
Aging (Albany NY). 2019 Nov 22;11(22):10626-10643. doi: 10.18632/aging.102481.
3
CircRNA circ-MYBL2 absorbs precursor miR-92b in the nucleus to suppress its role in enhancing gastric cancer cell proliferation.环状 RNA(circRNA)circ-MYBL2 在核内吸收前体 miR-92b,从而抑制其增强胃癌细胞增殖的作用。
Am J Med Sci. 2022 Oct;364(4):454-460. doi: 10.1016/j.amjms.2022.05.022. Epub 2022 May 27.
4
Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma.环状 RNA 表达谱的综合分析揭示了多发性骨髓瘤潜在的诊断和预后生物标志物。
BMC Cancer. 2020 Jan 16;20(1):40. doi: 10.1186/s12885-020-6515-2.
5
Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.环状 RNA hsa_circ_0043278 通过 miR-455-3p/EI24 信号通路抑制乳腺癌进展。
BMC Cancer. 2021 Nov 20;21(1):1249. doi: 10.1186/s12885-021-08989-w.
6
A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.一个 MYBL2 复合物促进 RRM2 的转录激活,以及 MYBL2 敲低与 WEE1 抑制联合对结直肠癌的增效作用。
Cell Death Dis. 2021 Jul 7;12(7):683. doi: 10.1038/s41419-021-03969-1.
7
miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.miR-30a 通过靶向 MYBL2、FOXD1 和 SOX4 抑制前列腺癌细胞的雄激素非依赖性生长。
Prostate. 2020 Jun;80(9):674-686. doi: 10.1002/pros.23979. Epub 2020 Apr 15.
8
CircRNA circ_0001821 predicts an unfavorable prognosis and promotes the proliferation of multiple myeloma.环状 RNA circ_0001821 预测多发性骨髓瘤预后不良,并促进其增殖。
Hematology. 2021 Dec;26(1):716-723. doi: 10.1080/16078454.2021.1974199.
9
Circular RNA circFAT1(e2) Facilitates Cell Progression through the miR-30e-5P/MYBL2 Pathway in Glioma.环状 RNA circFAT1(e2) 通过 miR-30e-5P/MYBL2 通路促进胶质瘤细胞的进展。
Dis Markers. 2023 Feb 1;2023:7418365. doi: 10.1155/2023/7418365. eCollection 2023.
10
LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.长链非编码 RNA LOXL1-AS1 通过海绵吸附 miR-423-5p 和靶向 MYBL2 调节肺腺癌的发生发展。
Cancer Med. 2020 Jan;9(2):689-699. doi: 10.1002/cam4.2641. Epub 2019 Nov 23.

引用本文的文献

1
Molecular epidemiological study of exosomes circZNF609, circPUM1, IGF2 with ischemic stroke.外泌体circZNF609、circPUM1、IGF2与缺血性脑卒中的分子流行病学研究
BMC Cardiovasc Disord. 2025 Mar 25;25(1):215. doi: 10.1186/s12872-025-04663-2.
2
CircRNAs in colorectal cancer: potential roles, clinical applications, and natural product-based regulation.结直肠癌中的环状RNA:潜在作用、临床应用及基于天然产物的调控
Front Oncol. 2025 Jan 29;15:1525779. doi: 10.3389/fonc.2025.1525779. eCollection 2025.
3
The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward.
多发性骨髓瘤的遗传和分子驱动因素:当前见解、临床意义及未来方向
Pharmgenomics Pers Med. 2024 Dec 21;17:573-609. doi: 10.2147/PGPM.S350238. eCollection 2024.
4
Circular RNA as Diagnostic and Prognostic Biomarkers in Hematological Malignancies:Systematic Review.环状 RNA 作为血液系统恶性肿瘤的诊断和预后生物标志物的系统评价。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241285149. doi: 10.1177/15330338241285149.
5
Recent Progress of CircRNAs in Hematological Malignancies.环状 RNA 在血液系统恶性肿瘤中的最新研究进展。
Int J Med Sci. 2024 Sep 30;21(13):2544-2561. doi: 10.7150/ijms.98156. eCollection 2024.
6
Circular RNA circXPO1 Promotes Multiple Myeloma Progression by Regulating miR-495-3p/DNA Damage-Induced Transcription 4 Axis.环状 RNA circXPO1 通过调控 miR-495-3p/DNA 损伤诱导转录因子 4 轴促进多发性骨髓瘤进展。
DNA Cell Biol. 2024 Jan;43(1):39-55. doi: 10.1089/dna.2023.0288. Epub 2023 Dec 11.
7
CircRNAs in diagnosis, prognosis, and clinicopathological features of multiple myeloma; a systematic review and meta-analysis.环状RNA在多发性骨髓瘤诊断、预后及临床病理特征中的作用;一项系统综述和荟萃分析
Cancer Cell Int. 2023 Aug 26;23(1):178. doi: 10.1186/s12935-023-03028-z.
8
Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression.解析 circRNA 对其宿主基因在肿瘤发生和肿瘤进展中的作用和调控模式。
J Exp Clin Cancer Res. 2023 Apr 15;42(1):86. doi: 10.1186/s13046-023-02657-6.
9
Circular RNA circFAT1(e2) Facilitates Cell Progression through the miR-30e-5P/MYBL2 Pathway in Glioma.环状 RNA circFAT1(e2) 通过 miR-30e-5P/MYBL2 通路促进胶质瘤细胞的进展。
Dis Markers. 2023 Feb 1;2023:7418365. doi: 10.1155/2023/7418365. eCollection 2023.
10
Hsa_Circ_0134426 Attenuates the Malignant Biological Behaviors of Multiple Myeloma by Suppressing miR-146b-3p to Upregulate NDNF.Hsa_Circ_0134426 通过抑制 miR-146b-3p 来上调 NDNF,从而抑制多发性骨髓瘤的恶性生物学行为。
Mol Biotechnol. 2023 Jul;65(7):1165-1177. doi: 10.1007/s12033-022-00618-6. Epub 2022 Dec 2.